CARDIFF ONCOLOGY, INC. (CRDF) Operating margin 2016–2025
CARDIFF ONCOLOGY, INC. (CRDF) operating margin by fiscal year — reported operating income divided by reported revenue.
-8256.3%FY2025 · since FY2016: -10534.9% → -8256.3%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -8256.3% | -1133.2 pp |
| FY2024 | -7123.1% | +2182.6 pp |
| FY2023 | -9305.7% | +1031.6 pp |
| FY2022 | -10337.3% | -2299.7 pp |
| FY2021 | -8037.6% | -2822.9 pp |
| FY2020 | -5214.8% | +1603.0 pp |
| FY2019 | -6817.8% | -2310.2 pp |
| FY2018 | -4507.6% | +556.8 pp |
| FY2017 | -5064.4% | +5470.5 pp |
| FY2016 | -10534.9% | — |
Operating margin = reported operating income ÷ reported revenue for the same fiscal year. Operating-loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice